Breast Cancer: Are Yearly Mammograms Worthwhile?
Nov. 21, 2012 -- Women over age 40 are often urged to get yearly mammograms with the promise that early detection is their best hope for beating breast cancer.
But a new study published in The New England Journal of Medicine suggests that mammograms may not save as many lives as doctors once thought.
The study also finds that the tests may be responsible for substantial harm, causing an estimated 1.3 million women in the U.S. over the last 30 years to be treated for breast cancers that would not have caused clinical symptoms.
“There’s a definite harm potential. It’s sizeable. It’s greater than we realized,” says researcher Archie Bleyer, MD, clinical research professor of radiation medicine at Oregon Health & Science University in Portland.
Bleyer says the study suggests that while mammograms are good and save lives, they should be used less often.
He supports guidelines from the U.S. Preventive Services Task Force that delay screening for most women until age 50 and only recommend tests every other year until age 75.
Other organizations, including the American Cancer Society and the American College of Obstetricians and Gynecologists, say women should get annual mammograms starting at age 40.
Len Lichtenfeld, MD, deputy chief medical officer at the American Cancer Society, says the study is interesting and will lead to more discussion about mammograms.
“It’s not a study that’s going to close the book, shall we say, on the discussion regarding the value of mammography,” says Lichtenfeld, who was not involved in the research.
Estimating Overdiagnosis of Breast Cancer
The study looked at trends in breast cancer detection in the U.S. from 1976 through 2008.
Researchers compared rates of breast cancer diagnoses before and after mammograms became widely used for screening. They adjusted their results to remove excess cancers thought to be related to the widespread use of hormone replacement therapy (HRT).
Mammograms did help find more early-stage breast cancers. But finding those cancers did not seem to prevent much late-stage disease. The number of late-stage breast cancers, which are most likely to be life-threatening, dropped only slightly, from 102 to 94 cases per 100,000 women.